Reported Earnings • Jul 14
First quarter 2027 earnings released: EPS: JP¥18.23 (vs JP¥9.32 in 1Q 2026) First quarter 2027 results: EPS: JP¥18.23 (up from JP¥9.32 in 1Q 2026). Revenue: JP¥2.06b (flat on 1Q 2026). Net income: JP¥90.0m (up 96% from 1Q 2026). Profit margin: 4.4% (up from 2.2% in 1Q 2026). Over the last 3 years on average, earnings per share has fallen by 50% per year but the company’s share price has only fallen by 19% per year, which means it has not declined as severely as earnings. Announcement • Jul 13
CVS Bay Area Inc. to Report Q2, 2027 Results on Oct 09, 2026 CVS Bay Area Inc. announced that they will report Q2, 2027 results on Oct 09, 2026 New Risk • Apr 17
New major risk - Dividend sustainability The dividend is not well covered by earnings and cash flows. The company is paying a dividend despite being loss-making. The company is paying a dividend despite having no free cash flows. Dividend yield: 3.9% This is considered a major risk. Companies that pay out too much of their earnings and cash flows are at risk of having to reduce or cut their dividend in future. If earnings or cash flows stagnate or fall, then there may not be enough to maintain the same dividend. Or in extreme cases, companies may opt to dig into capital reserves or take on debt to maintain the dividend. For dividend paying companies, any reduction in the dividend can significantly impact the share price. Currently, the following risks have been identified for the company: Major Risks Interest payments are not well covered by earnings (1.9x net interest cover). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Minor Risk Market cap is less than US$100m (JP¥2.52b market cap, or US$15.8m). Reported Earnings • Apr 14
Full year 2026 earnings released: JP¥231 loss per share (vs JP¥227 profit in FY 2025) Full year 2026 results: JP¥231 loss per share (down from JP¥227 profit in FY 2025). Revenue: JP¥7.90b (up 1.0% from FY 2025). Net loss: JP¥1.14b (down 201% from profit in FY 2025). Over the last 3 years on average, earnings per share has fallen by 13% per year but the company’s share price has increased by 2% per year, which means it is well ahead of earnings. Announcement • Apr 13
CVS Bay Area Inc., Annual General Meeting, May 27, 2026 CVS Bay Area Inc., Annual General Meeting, May 27, 2026. Buy Or Sell Opportunity • Apr 08
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 2.7% to JP¥504. The fair value is estimated to be JP¥632, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.7% over the last 3 years. Meanwhile, the company has become profitable. Announcement • Apr 02
CVS Bay Area Inc. to Report Fiscal Year 2026 Results on Apr 10, 2026 CVS Bay Area Inc. announced that they will report fiscal year 2026 results on Apr 10, 2026 Buy Or Sell Opportunity • Mar 02
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 3.8% to JP¥503. The fair value is estimated to be JP¥632, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 4.7% over the last 3 years. Meanwhile, the company has become profitable. Upcoming Dividend • Feb 19
Upcoming dividend of JP¥10.00 per share Eligible shareholders must have bought the stock before 26 February 2026. Payment date: 13 May 2026. Payout ratio is a comfortable 64% but the company is not cash flow positive. Trailing yield: 4.9%. Within top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (1.5%). New Risk • Jan 10
New minor risk - Earnings quality The company has large one-off items impacting its financial results. One-off items were 29% of the size of the rest of the company's trailing 12-month earnings before tax. This is considered a minor risk. One-off items are incomes or expenses that the company does not expect to repeat in future periods. Examples include profits from the sale of a business or expenses from a restructuring or legal settlements. If the company's reported statutory earnings include a large proportion of one-off items it means they may be an unreliable indicator of its true business performance as the earnings were skewed by these incomes or expenses. Currently, the following risks have been identified for the company: Major Risk Interest payments are not well covered by earnings (1.3x net interest cover). Minor Risks Paying a dividend despite having no free cash flows. Large one-off items impacting financial results. Profit margins are more than 30% lower than last year (2.2% net profit margin). Market cap is less than US$100m (JP¥2.55b market cap, or US$16.1m). Reported Earnings • Jan 10
Third quarter 2026 earnings released: EPS: JP¥7.90 (vs JP¥21.07 in 3Q 2025) Third quarter 2026 results: EPS: JP¥7.90 (down from JP¥21.07 in 3Q 2025). Revenue: JP¥2.03b (down 1.2% from 3Q 2025). Net income: JP¥39.0m (down 63% from 3Q 2025). Profit margin: 1.9% (down from 5.1% in 3Q 2025). Over the last 3 years on average, earnings per share has increased by 50% per year but the company’s share price has only increased by 9% per year, which means it is significantly lagging earnings growth. Buy Or Sell Opportunity • Dec 22
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 18% to JP¥493. The fair value is estimated to be JP¥619, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has grown by 5.3% over the last 3 years. Meanwhile, the company has become profitable. Reported Earnings • Oct 15
Second quarter 2026 earnings released: JP¥22.69 loss per share (vs JP¥133 profit in 2Q 2025) Second quarter 2026 results: JP¥22.69 loss per share (down from JP¥133 profit in 2Q 2025). Revenue: JP¥1.90b (flat on 2Q 2025). Net loss: JP¥112.0m (down 117% from profit in 2Q 2025). Over the last 3 years on average, earnings per share has increased by 80% per year but the company’s share price has only increased by 11% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Aug 21
Upcoming dividend of JP¥13.00 per share Eligible shareholders must have bought the stock before 28 August 2025. Payment date: 11 November 2025. Payout ratio is a comfortable 11% but the company is not cash flow positive. Trailing yield: 4.1%. Within top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.6%). Reported Earnings • Jul 14
First quarter 2026 earnings released: EPS: JP¥9.32 (vs JP¥31.60 in 1Q 2025) First quarter 2026 results: EPS: JP¥9.32 (down from JP¥31.60 in 1Q 2025). Revenue: JP¥2.08b (up 4.0% from 1Q 2025). Net income: JP¥46.0m (down 71% from 1Q 2025). Profit margin: 2.2% (down from 7.8% in 1Q 2025). Over the last 3 years on average, earnings per share has increased by 102% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jun 03
Full year 2025 earnings released: EPS: JP¥227 (vs JP¥141 in FY 2024) Full year 2025 results: EPS: JP¥227 (up from JP¥141 in FY 2024). Revenue: JP¥7.82b (up 4.0% from FY 2024). Net income: JP¥1.12b (up 61% from FY 2024). Profit margin: 14% (up from 9.3% in FY 2024). Over the last 3 years on average, earnings per share has increased by 113% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. New Risk • Apr 15
New major risk - Earnings quality The company has a high level of non-cash earnings. Accrual ratio: 30% This is considered a major risk. Non-cash earnings can arise from many different things. However, if a company consistently has a high level of non-cash earnings, it may be a sign that they are recognizing revenue from customers before the full value of the sales are received as cash or they are not depreciating the value of their assets appropriately. These are practices that inflate earnings, while not providing a similar increase to cash flows. Companies in some select industries naturally have a high level of non-cash earnings and it is not a major concern. However, in the worst case scenario it can be an early sign of performance manipulation by management. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (7.8% operating cash flow to total debt). High level of non-cash earnings (30% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Market cap is less than US$100m (JP¥2.65b market cap, or US$18.5m). Announcement • Apr 14
CVS Bay Area Inc., Annual General Meeting, May 28, 2025 CVS Bay Area Inc., Annual General Meeting, May 28, 2025. Reported Earnings • Apr 12
Full year 2025 earnings released: EPS: JP¥227 (vs JP¥141 in FY 2024) Full year 2025 results: EPS: JP¥227 (up from JP¥141 in FY 2024). Revenue: JP¥7.82b (up 4.0% from FY 2024). Net income: JP¥1.12b (up 61% from FY 2024). Profit margin: 14% (up from 9.3% in FY 2024). Over the last 3 years on average, earnings per share has increased by 113% per year but the company’s share price has only increased by 14% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Feb 20
Upcoming dividend of JP¥10.00 per share Eligible shareholders must have bought the stock before 27 February 2025. Payment date: 13 May 2025. Payout ratio is a comfortable 4.0% but the company is not cash flow positive. Trailing yield: 3.6%. Lower than top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (1.6%). Announcement • Feb 03
CVS Bay Area Inc. to Report Fiscal Year 2024 Results on Apr 11, 2025 CVS Bay Area Inc. announced that they will report fiscal year 2024 results on Apr 11, 2025 Reported Earnings • Jan 15
Third quarter 2025 earnings released: EPS: JP¥21.07 (vs JP¥31.20 in 3Q 2024) Third quarter 2025 results: EPS: JP¥21.07 (down from JP¥31.20 in 3Q 2024). Revenue: JP¥2.06b (up 7.9% from 3Q 2024). Net income: JP¥104.0m (down 33% from 3Q 2024). Profit margin: 5.1% (down from 8.1% in 3Q 2024). Over the last 3 years on average, earnings per share has increased by 118% per year but the company’s share price has only increased by 13% per year, which means it is significantly lagging earnings growth. Announcement • Oct 28
CVS Bay Area Inc. to Report Q3, 2025 Results on Jan 10, 2025 CVS Bay Area Inc. announced that they will report Q3, 2025 results on Jan 10, 2025 Reported Earnings • Oct 16
Second quarter 2025 earnings released: EPS: JP¥133 (vs JP¥20.87 in 2Q 2024) Second quarter 2025 results: EPS: JP¥133 (up from JP¥20.87 in 2Q 2024). Revenue: JP¥1.90b (up 4.0% from 2Q 2024). Net income: JP¥659.0m (up JP¥556.0m from 2Q 2024). Profit margin: 35% (up from 5.6% in 2Q 2024). Over the last 3 years on average, earnings per share has increased by 117% per year but the company’s share price has only increased by 12% per year, which means it is significantly lagging earnings growth. New Risk • Sep 17
New major risk - Financial data availability The company has not reported any financial data. This is considered a major risk. With no or incomplete audited reported financial data, it is virtually impossible to assess the company's investment potential. Currently, the following risks have been identified for the company: Major Risk No financial data reported. Minor Risks Unstable dividend paying track record with dividend experiencing an annual drop of over 20% in the past. Market cap is less than US$100m (JP¥2.80b market cap, or US$19.9m). Upcoming Dividend • Aug 22
Upcoming dividend of JP¥10.00 per share Eligible shareholders must have bought the stock before 29 August 2024. Payment date: 13 November 2024. Payout ratio is a comfortable 14% but the company is not cash flow positive. Trailing yield: 3.3%. Lower than top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (1.7%). Valuation Update With 7 Day Price Move • Aug 05
Investor sentiment deteriorates as stock falls 25% After last week's 25% share price decline to JP¥525, the stock trades at a trailing P/E ratio of 3.6x. Average trailing P/E is 12x in the Consumer Retailing industry in Japan. Total returns to shareholders of 38% over the past three years. Announcement • Jul 30
CVS Bay Area Inc. to Report Q2, 2025 Results on Oct 11, 2024 CVS Bay Area Inc. announced that they will report Q2, 2025 results on Oct 11, 2024 Reported Earnings • Jul 12
First quarter 2025 earnings released: EPS: JP¥31.60 (vs JP¥27.55 in 1Q 2024) First quarter 2025 results: EPS: JP¥31.60 (up from JP¥27.55 in 1Q 2024). Revenue: JP¥2.00b (up 4.0% from 1Q 2024). Net income: JP¥156.0m (up 15% from 1Q 2024). Profit margin: 7.8% (up from 7.1% in 1Q 2024). The increase in margin was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 107% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jun 01
Full year 2024 earnings released: EPS: JP¥141 (vs JP¥2.63 loss in FY 2023) Full year 2024 results: EPS: JP¥141 (up from JP¥2.63 loss in FY 2023). Revenue: JP¥7.52b (up 8.6% from FY 2023). Net income: JP¥697.0m (up JP¥710.0m from FY 2023). Profit margin: 9.3% (up from net loss in FY 2023). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 96% per year but the company’s share price has only increased by 15% per year, which means it is significantly lagging earnings growth. Buy Or Sell Opportunity • May 30
Now 20% undervalued after recent price drop Over the last 90 days, the stock has fallen 12% to JP¥606. The fair value is estimated to be JP¥761, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. New Risk • May 20
New minor risk - Share price stability The company's share price has been volatile over the past 3 months. It is more volatile than 75% of Japanese stocks, typically moving 5.8% a week. This is considered a minor risk. Share price volatility indicates the stock is highly sensitive to market conditions or economic conditions rather than being sensitive to its own business performance, which may also be inconsistent. It also increases the risk of potential losses in the short term as the stock tends to have larger drops in price more frequently than other stocks. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (9.0% operating cash flow to total debt). Earnings have declined by 15% per year over the past 5 years. High level of non-cash earnings (22% accrual ratio). Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (5.8% average weekly change). Market cap is less than US$100m (JP¥3.06b market cap, or US$19.7m). Buy Or Sell Opportunity • May 11
Now 21% undervalued after recent price drop Over the last 90 days, the stock has fallen 24% to JP¥572. The fair value is estimated to be JP¥726, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Announcement • May 01
CVS Bay Area Inc. to Report Q1, 2025 Results on Jul 10, 2024 CVS Bay Area Inc. announced that they will report Q1, 2025 results on Jul 10, 2024 Valuation Update With 7 Day Price Move • Apr 19
Investor sentiment deteriorates as stock falls 19% After last week's 19% share price decline to JP¥593, the stock trades at a trailing P/E ratio of 4.2x. Average trailing P/E is 14x in the Consumer Retailing industry in Japan. Total returns to shareholders of 60% over the past three years. Buy Or Sell Opportunity • Apr 15
Now 26% undervalued after recent price drop Over the last 90 days, the stock has fallen 18% to JP¥583. The fair value is estimated to be JP¥788, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has been flat over the last 3 years. Meanwhile, the company has become profitable. Announcement • Apr 14
CVS Bay Area Inc., Annual General Meeting, May 29, 2024 CVS Bay Area Inc., Annual General Meeting, May 29, 2024. Reported Earnings • Apr 14
Full year 2024 earnings released: EPS: JP¥141 (vs JP¥2.63 loss in FY 2023) Full year 2024 results: EPS: JP¥141 (up from JP¥2.63 loss in FY 2023). Revenue: JP¥7.52b (up 8.6% from FY 2023). Net income: JP¥697.0m (up JP¥710.0m from FY 2023). Profit margin: 9.3% (up from net loss in FY 2023). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 96% per year but the company’s share price has only increased by 19% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Feb 21
Upcoming dividend of JP¥10.00 per share Eligible shareholders must have bought the stock before 28 February 2024. Payment date: 15 May 2024. Payout ratio is a comfortable 19% but the company is not cash flow positive. Trailing yield: 2.8%. Lower than top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (1.5%). Announcement • Feb 02
CVS Bay Area Inc. to Report Fiscal Year 2024 Results on Apr 12, 2024 CVS Bay Area Inc. announced that they will report fiscal year 2024 results on Apr 12, 2024 Reported Earnings • Jan 12
Third quarter 2024 earnings released: EPS: JP¥31.20 (vs JP¥0.41 loss in 3Q 2023) Third quarter 2024 results: EPS: JP¥31.20 (up from JP¥0.41 loss in 3Q 2023). Revenue: JP¥1.91b (up 7.9% from 3Q 2023). Net income: JP¥154.0m (up JP¥156.0m from 3Q 2023). Profit margin: 8.1% (up from net loss in 3Q 2023). Over the last 3 years on average, earnings per share has increased by 82% per year but the company’s share price has only increased by 24% per year, which means it is significantly lagging earnings growth. Reported Earnings • Oct 12
Second quarter 2024 earnings released: EPS: JP¥20.87 (vs JP¥12.76 loss in 2Q 2023) Second quarter 2024 results: EPS: JP¥20.87 (up from JP¥12.76 loss in 2Q 2023). Revenue: JP¥1.83b (up 8.2% from 2Q 2023). Net income: JP¥103.0m (up JP¥166.0m from 2Q 2023). Profit margin: 5.6% (up from net loss in 2Q 2023). The move to profitability was primarily driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 62% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Valuation Update With 7 Day Price Move • Aug 24
Investor sentiment improves as stock rises 24% After last week's 24% share price gain to JP¥1,002, the stock trades at a trailing P/E ratio of 35.8x. Average trailing P/E is 14x in the Consumer Retailing industry in Japan. Total returns to shareholders of 169% over the past three years. Upcoming Dividend • Aug 23
Upcoming dividend of JP¥10.00 per share at 2.2% yield Eligible shareholders must have bought the stock before 30 August 2023. Payment date: 14 November 2023. Payout ratio is a comfortable 57% but the company is not cash flow positive. Trailing yield: 2.2%. Lower than top quartile of Japanese dividend payers (3.5%). Higher than average of industry peers (1.6%). Valuation Update With 7 Day Price Move • Jul 20
Investor sentiment improves as stock rises 25% After last week's 25% share price gain to JP¥873, the stock trades at a trailing P/E ratio of 31.2x. Average trailing P/E is 15x in the Consumer Retailing industry in Japan. Total returns to shareholders of 107% over the past three years. New Risk • Jul 16
New major risk - Financial position The company's debt is not well covered by operating cash flow. Currently running at an operating cash loss. This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (currently running at an operating cash loss). Earnings have declined by 62% per year over the past 5 years. Minor Risks Paying a dividend despite having no free cash flows. Share price has been volatile over the past 3 months (7.2% average weekly change). Market cap is less than US$100m (JP¥3.94b market cap, or US$28.4m). Reported Earnings • Jul 16
First quarter 2024 earnings released: EPS: JP¥27.55 (vs JP¥3.04 loss in 1Q 2023) First quarter 2024 results: EPS: JP¥27.55 (up from JP¥3.04 loss in 1Q 2023). Revenue: JP¥1.92b (up 15% from 1Q 2023). Net income: JP¥136.0m (up JP¥151.0m from 1Q 2023). Profit margin: 7.1% (up from net loss in 1Q 2023). The move to profitability was driven by higher revenue. Over the last 3 years on average, earnings per share has increased by 42% per year but the company’s share price has only increased by 20% per year, which means it is significantly lagging earnings growth. Reported Earnings • Jun 02
Full year 2023 earnings released: JP¥2.63 loss per share (vs JP¥168 loss in FY 2022) Full year 2023 results: JP¥2.63 loss per share (improved from JP¥168 loss in FY 2022). Revenue: JP¥6.93b (down 3.9% from FY 2022). Net loss: JP¥13.0m (loss narrowed 98% from FY 2022). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 1% per year, which means it is significantly lagging earnings growth. Announcement • May 28
CVS Bay Area Inc. to Report Q1, 2024 Results on Jul 12, 2023 CVS Bay Area Inc. announced that they will report Q1, 2024 results on Jul 12, 2023 Reported Earnings • Apr 13
Full year 2023 earnings released: JP¥2.63 loss per share (vs JP¥168 loss in FY 2022) Full year 2023 results: JP¥2.63 loss per share (improved from JP¥168 loss in FY 2022). Revenue: JP¥6.93b (down 3.9% from FY 2022). Net loss: JP¥13.0m (loss narrowed 98% from FY 2022). Over the last 3 years on average, earnings per share has increased by 18% per year but the company’s share price has only increased by 7% per year, which means it is significantly lagging earnings growth. Upcoming Dividend • Feb 20
Upcoming dividend of JP¥8.00 per share at 3.8% yield Eligible shareholders must have bought the stock before 27 February 2023. Payment date: 16 May 2023. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.8%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.6%). Reported Earnings • Jan 12
Third quarter 2023 earnings released: JP¥0.41 loss per share (vs JP¥11.95 loss in 3Q 2022) Third quarter 2023 results: JP¥0.41 loss per share (improved from JP¥11.95 loss in 3Q 2022). Revenue: JP¥1.77b (flat on 3Q 2022). Net loss: JP¥2.00m (loss narrowed 97% from 3Q 2022). Over the last 3 years on average, earnings per share has fallen by 7% per year but the company’s share price has fallen by 16% per year, which means it is performing significantly worse than earnings. Announcement • Nov 30
CVS Bay Area Inc. to Report Q3, 2023 Results on Jan 11, 2023 CVS Bay Area Inc. announced that they will report Q3, 2023 results on Jan 11, 2023 Board Change • Nov 16
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 5 experienced directors. 4 highly experienced directors. No independent directors (9 non-independent directors). Director Mario Izumisawa was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Reported Earnings • Oct 13
Second quarter 2023 earnings released: JP¥12.76 loss per share (vs JP¥7.90 loss in 2Q 2022) Second quarter 2023 results: JP¥12.76 loss per share (further deteriorated from JP¥7.90 loss in 2Q 2022). Revenue: JP¥1.69b (down 9.5% from 2Q 2022). Net loss: JP¥63.0m (loss widened 62% from 2Q 2022). Over the last 3 years on average, earnings per share has fallen by 31% per year but the company’s share price has only fallen by 16% per year, which means it has not declined as severely as earnings. Announcement • Aug 27
CVS Bay Area Inc. to Report Q2, 2023 Results on Oct 12, 2022 CVS Bay Area Inc. announced that they will report Q2, 2023 results on Oct 12, 2022 Upcoming Dividend • Aug 23
Upcoming dividend of JP¥8.00 per share Eligible shareholders must have bought the stock before 30 August 2022. Payment date: 15 November 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.9%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (1.6%). Reported Earnings • Jul 17
First quarter 2023 earnings released: JP¥3.04 loss per share (vs JP¥38.49 loss in 1Q 2022) First quarter 2023 results: JP¥3.04 loss per share (up from JP¥38.49 loss in 1Q 2022). Revenue: JP¥1.66b (down 9.9% from 1Q 2022). Net loss: JP¥15.0m (loss narrowed 92% from 1Q 2022). Over the last 3 years on average, earnings per share has fallen by 52% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings. Reported Earnings • Jun 03
Full year 2022 earnings released: JP¥168 loss per share (vs JP¥235 loss in FY 2021) Full year 2022 results: JP¥168 loss per share (up from JP¥235 loss in FY 2021). Revenue: JP¥7.21b (down 1.5% from FY 2021). Net loss: JP¥831.0m (loss narrowed 28% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 83 percentage points per year, which is a significant difference in performance. Announcement • May 25
CVS Bay Area Inc. to Report Q1, 2023 Results on Jul 13, 2022 CVS Bay Area Inc. announced that they will report Q1, 2023 results on Jul 13, 2022 Board Change • Apr 27
No independent directors No new directors have joined the board in the last 3 years. The company's board is composed of: No new directors. 7 experienced directors. 2 highly experienced directors. No independent directors (9 non-independent directors). Director Mario Izumisawa was the last director to join the board, commencing their role in 2014. The following issues are considered to be risks according to the Simply Wall St Risk Model: Lack of independent directors. Insufficient board refreshment. Announcement • Apr 15
CVS Bay Area Inc., Annual General Meeting, May 31, 2022 CVS Bay Area Inc., Annual General Meeting, May 31, 2022. Reported Earnings • Apr 14
Full year 2022 earnings released: JP¥168 loss per share (vs JP¥235 loss in FY 2021) Full year 2022 results: JP¥168 loss per share (up from JP¥235 loss in FY 2021). Revenue: JP¥7.21b (down 1.5% from FY 2021). Net loss: JP¥831.0m (loss narrowed 28% from FY 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 80 percentage points per year, which is a significant difference in performance. Announcement • Apr 08
CVS Bay Area Inc. to Report Fiscal Year 2022 Results on Apr 13, 2022 CVS Bay Area Inc. announced that they will report fiscal year 2022 results on Apr 13, 2022 Upcoming Dividend • Feb 18
Upcoming dividend of JP¥8.00 per share Eligible shareholders must have bought the stock before 25 February 2022. Payment date: 13 May 2022. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.1%. Lower than top quartile of Japanese dividend payers (3.4%). Higher than average of industry peers (1.6%). Reported Earnings • Jan 13
Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations Third quarter 2022 results: JP¥11.95 loss per share (up from JP¥64.02 loss in 3Q 2021). Revenue: JP¥1.77b (down 5.6% from 3Q 2021). Net loss: JP¥59.0m (loss narrowed 81% from 3Q 2021). Revenue was in line with analyst estimates. Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 97 percentage points per year, which is a significant difference in performance. Reported Earnings • Oct 16
Second quarter 2022 earnings released: JP¥7.90 loss per share (vs JP¥15.19 profit in 2Q 2021) The company reported a poor second quarter result with weaker earnings, revenues and control over costs. Second quarter 2022 results: Revenue: JP¥1.87b (down 4.7% from 2Q 2021). Net loss: JP¥39.0m (down 152% from profit in 2Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 102 percentage points per year, which is a significant difference in performance. Upcoming Dividend • Aug 23
Upcoming dividend of JP¥8.00 per share Eligible shareholders must have bought the stock before 30 August 2021. Payment date: 16 November 2021. Trailing yield: 4.0%. Within top quartile of Japanese dividend payers (3.1%). Higher than average of industry peers (1.4%). Reported Earnings • Jul 16
First quarter 2022 earnings released: JP¥38.49 loss per share (vs JP¥71.31 loss in 1Q 2021) The company reported a solid first quarter result with reduced losses, improved revenues and improved control over expenses. First quarter 2022 results: Revenue: JP¥1.85b (up 8.1% from 1Q 2021). Net loss: JP¥190.0m (loss narrowed 46% from 1Q 2021). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 100 percentage points per year, which is a significant difference in performance. Reported Earnings • Jun 03
Full year 2021 earnings released: JP¥235 loss per share (vs JP¥81.24 loss in FY 2020) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: JP¥7.32b (down 30% from FY 2020). Net loss: JP¥1.16b (loss widened 189% from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 78 percentage points per year, which is a significant difference in performance. Reported Earnings • Apr 28
Full year 2021 earnings released: JP¥235 loss per share (vs JP¥81.24 loss in FY 2020) The company reported a poor full year result with increased losses, weaker revenues and weaker control over costs. Full year 2021 results: Revenue: JP¥7.32b (down 30% from FY 2020). Net loss: JP¥1.16b (loss widened 189% from FY 2020). Over the last 3 years on average, the company's share price growth rate has exceeded its earnings growth rate by 77 percentage points per year, which is a significant difference in performance. Announcement • Feb 20
CVS Bay Area Inc. to Report Fiscal Year 2021 Results on Apr 14, 2021 CVS Bay Area Inc. announced that they will report fiscal year 2021 results on Apr 14, 2021 Reported Earnings • Jan 15
Third quarter 2021 earnings released: JP¥64.02 loss per share The company reported a poor third quarter result with weaker earnings, revenues and control over expenses. Third quarter 2021 results: Revenue: JP¥1.87b (down 27% from 3Q 2020). Net loss: JP¥316.0m (down JP¥385.0m from profit in 3Q 2020). Over the last 3 years on average, earnings per share has fallen by 74% per year but the company’s share price has only fallen by 18% per year, which means it has not declined as severely as earnings. Is New 90 Day High Low • Dec 18
New 90-day low: JP¥402 The company is down 12% from its price of JP¥458 on 18 September 2020. The Japanese market is up 9.0% over the last 90 days, indicating the company underperformed over that time. It also underperformed the Consumer Retailing industry, which is up 1.0% over the same period. Announcement • Aug 23
CVS Bay Area Inc. to Report Q2, 2021 Results on Oct 14, 2020 CVS Bay Area Inc. announced that they will report Q2, 2021 results on Oct 14, 2020 Announcement • Aug 04
CVS Bay Area Inc. to Report Q1, 2021 Results on Jul 30, 2020 CVS Bay Area Inc. announced that they will report Q1, 2021 results on Jul 30, 2020